by | Jun 12, 2026 | Lee, Jeongmin, Piston, David, Ustione, Alessandro
— Published date: 6/13/2026
Value Proposition: Novel glucagon regulator and therapeutic for diabetes
Technology Description
Researchers from the laboratory of Dr. David Piston at Washington University have discovered and isolated a peptide-based treatment from brown adipose tissue that normal…
by | Feb 2, 2024 | Asadi Jomnani, Farzad, Dolle, Roland "Ron", Piston, David
— T-020153 – Small Molecule Agonists of EphA Receptors to Ameliorate Diabetes
Technology Description
Blood glucose levels (left), post-treatment plasma glucagon (center) in WCDD301 treated NOD (non-obese diabetic) mice with moderate hyperglycemia. Blood glucose levels (right) in Streptozotocin-ind…
by | Aug 13, 2020 | Foust, Daniel, Piston, David
— New combinations of labeled membrane proteins and G-protein subunits. These include twocolor HRas and single color CD86 controls as well as labels beta and gamma subunits of the heterotrimeric G-protein complex. All of these have been built using plasmids from Addgene.